Time to get proper diagnosis in multiple sclerosis and start disease-modifying therapy: the Highlands MS incidence study

被引：0
|
作者：
Artal, F. J. Carod [1 ]
机构：
[1] Raigmore Hosp, NHS Highlands, Neurol Dept, Inverness, Scotland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1354
引用
收藏
页码：769 / 770
页数：2
相关论文
共 50 条
  • [21] Evaluating response to disease-modifying therapy in relapsing multiple sclerosis
    Freedman, Mark S.
    Abdoli, Mohammad
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (04) : 407 - 423
  • [22] Patient choice and adherence with disease-modifying therapy in multiple sclerosis
    Burke, G
    Pozo, A
    Nairne, A
    Birmingham, H
    Gregory, R
    Palace, JA
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S189 - S189
  • [23] Disease-modifying therapy in multiple sclerosis Update and clinical implications
    Goodin, Douglas S.
    NEUROLOGY, 2008, 71 (24) : S8 - S13
  • [24] Impact of Race on Use of Disease-Modifying Therapy in Multiple Sclerosis
    Hyland, Megan
    Cohen, Jeffrey
    Stone, Lael
    NEUROLOGY, 2013, 80
  • [25] Fingolimod: an Oral Disease-Modifying Therapy for Relapsing Multiple Sclerosis
    Yeh, E. Ann
    Weinstock-Guttman, B.
    ADVANCES IN THERAPY, 2011, 28 (04) : 270 - 278
  • [26] Factors that influence adherence with disease-modifying therapy in multiple sclerosis
    Treadaway, K
    Hawker, K
    Racke, M
    Brannon, K
    Morrison, A
    Remington, G
    Frohman, E
    Cohen, B
    Corboy, J
    Simsarian, J
    Lynch, S
    Jeffery, D
    MULTIPLE SCLEROSIS, 2005, 11 : S158 - S158
  • [27] Infections in patients with multiple sclerosis: Implications for disease-modifying therapy
    Celius, E. G.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 : 34 - 36
  • [28] Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis
    E. Ann Yeh
    B. Weinstock-Guttman
    Advances in Therapy, 2011, 28 : 270 - 278
  • [29] Disease-modifying therapy in multiple sclerosis: Strategies for optimizing management
    Frohman, E
    Phillips, T
    Kokel, K
    Van Pelt, J
    O'Leary, S
    Gross, S
    Hawker, K
    Racke, M
    NEUROLOGIST, 2002, 8 (04) : 227 - 236
  • [30] Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis
    Hartung, Hans-Peter
    Meuth, Sven G.
    Miller, Deborah M.
    Comi, Giancarlo
    CURRENT OPINION IN NEUROLOGY, 2021, 34 (04) : 598 - 603
12345